Home › Funds › Aristotle Capital Boston, LLC › HQY
Aristotle Capital Boston, LLC position in HQY
HEALTHEQUITY INC · Consumer Discretionary
Aristotle Capital Boston, LLC reported holding 268,343 shares of HQY (HEALTHEQUITY INC) in its Q3 2026 13F filing — a position valued at US$23.7M, representing 2.10% of its reported portfolio and ranking #5 among its reported holdings. Aristotle Capital Boston, LLC has disclosed HQY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Aristotle Capital Boston, LLC's HQY position evolved
Aristotle Capital Boston, LLC first disclosed a stake in HQY in Q3 2023 at 621,034 shares (US$45.4M). The position peaked in Q4 2024 at 573,441 shares, worth US$55.0M. Across 13 filings, Aristotle Capital Boston, LLC increased the stake 1 time(s), trimmed it 11 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 268,343 shares valued at US$23.7M — a reduction of -64,541 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 621.03K | $45.37M | New |
| Q4 2023 | 599.39K | $39.74M | Reduce |
| Q1 2024 | 582.66K | $47.56M | Reduce |
| Q2 2024 | 541.49K | $46.68M | Reduce |
| Q3 2024 | 538.31K | $44.06M | Reduce |
| Q4 2024 | 573.44K | $55.02M | Add |
| Q1 2025 | 477.64K | $42.21M | Reduce |
| Q2 2025 | 443.32K | $46.44M | Reduce |
| Q3 2025 | 436.03K | $41.32M | Reduce |
| Q4 2025 | 432.94K | $39.66M | Reduce |
| Q1 2026 | 397.23K | $33.17M | Reduce |
| Q2 2026 | 332.88K | $30.07M | Reduce |
| Q3 2026 | 268.34K | $23.74M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HQY and 13F data
HQY (HEALTHEQUITY INC) is a Consumer Discretionary company. 32 other funds we track also report a position in HQY — the largest reported positions include WASATCH ADVISORS LP (US$620.2M), GENEVA CAPITAL MANAGEMENT LLC (US$97.8M), Greenhouse Funds LLLP (US$88.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HQY
- WASATCH ADVISORS LP 7.01M sh · $620.23M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.11M sh · $97.84M · Q3 2026
- Greenhouse Funds LLLP 1.00M sh · $88.66M · Q3 2026
- GW&K Investment Management, LLC 989.43K sh · $87.53M · Q3 2026
- Stephens Investment Management Group LLC 977.00K sh · $86.43M · Q3 2026
More on Aristotle Capital Boston, LLC
FAQ
How long has Aristotle Capital Boston, LLC held HQY?
Aristotle Capital Boston, LLC has disclosed HQY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Aristotle Capital Boston, LLC's current position in HQY?
As of Q3 2026, Aristotle Capital Boston, LLC holds 268.34K shares of HQY (HEALTHEQUITY INC), valued at $23.74M, representing 2.10% of its reported portfolio and ranking #5.
Has Aristotle Capital Boston, LLC been buying or selling HQY?
In the latest 13F filing (Q3 2026), Aristotle Capital Boston, LLC reduced its position in HQY. The position peaked in Q4 2024 at 573.44K shares.
Which other funds hold HQY?
Other major institutional holders of HQY include WASATCH ADVISORS LP, GENEVA CAPITAL MANAGEMENT LLC, Greenhouse Funds LLLP, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.